OUR LEADERSHIP
Practice Leadership
Allan Miller
Allan Miller is a Partner at Equinox Group. He received an M.A. and a Ph.D. in Molecular Biology from the University of Cambridge. His focuses are oncology, virology, and patient flow modeling techniques.
Jack Lindberg
Jack Lindberg is a Partner at Equinox Group. He received a B.S. in Business Economics from Bentley University and an M.S. in Pharmaceutical Economics and Policy from MCPHS University. His focuses are unmet medical need analysis, R&D decision support, and competitive dynamics.
Kaycee Chakrapani
Kamakshi (Kaycee) Chakrapani is a senior consultant at Equinox Group. She received a B.S. from the Institute of Chemical Technology (Formerly UDCT), Mumbai. She also holds a Master’s from the Thayer School of Engineering at Dartmouth College. Her focus is on forecasting, patient flow modeling techniques, and epidemiology.
Our Founders
David Godolphin
David Godolphin is a co-founder of Equinox Group. He received an A.B. from Harvard College. His focuses are unmet medical need analysis, forecasting, and drug development strategy.
Walter Brooks
Walter Brooks is a co-founder of Equinox Group. He holds a B.A. in Economics and an M.S. in Policy Analysis from SUNY at Stony Brook. His focus is R&D decision support, concentrating on biopharmaceuticals since 1988.